Concept Richtlijn Erfelijke darmkanker 2007 versie 7 - Oncoline

13. Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Sprangers MA, Obertop H et al.Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy andileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2000;87:590-6.14. Fornasarig M, Minisini AM, Viel A,Quaia M, Canzonieri V, Veronesi A. Twelve years ofendoscopic surveillance in a family carrying biallelic Y165C MYH defect: report of a case.Dis Colon Rectum 2006;49:1-4.15. Giardiello FM, Casero RA Jr, Hamilton SR, Hylind HMN, Trimbath JD, Geiman DE et al.Prostanoids, ornithine decarboxylase and polyamines in primary chemoprevention offamilial adenomatous polyposis. Gastroenterology 2004;49:1259-61.16. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditarycolorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.17. Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z et al.Relationship etween APC genotype, polyp distribution and oral sulindac treatment in thecolon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum2001;44:1090-7.18. Higuchi, T, Iwama, T, Yoshinaga, K, Toyooka M, Taketo MM, Sgihara K.A randomized,double-blind, placebo-controlled trial of the effects of rofecoxib, a selectivecyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.Clin Cancer Res 2003;9:4756-6019. Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempour C. Restorativeproctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposisrevisited. Fam Cancer 2006;5:241-60.20. Kiesslich R, von Bergh M, Hahn M, Hermann G, Jung M. Chromoendoscopy withindigocarmine improves the detection of adenomatous and nonadenomatous lesions inthe colon. Endoscopy 2001;33:1001-6.21. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C et al. Sulindac causesregression of rectal polyps in familial adenomatous polyposis, Gastroenterology1991;101:635-922. Maartense S, Dunker M, Slors JF, Cuesta MA, Gouma DJ, van Deventer SJ et al. Handassistedlaparoscopic versus open restorative proctocolectomy with ileal pouch-analanastomosis. A randomised trial. Ann Surg 2004;240:984-92.23. Meyskens FL Jr. Chemoprevention of FAP with sulindac. Curr Oncol Rep. 2002;4:463.24. Niv Y, Fraser GM. Adenocarcinoma in the rectal remnant in familial polyposis coli is notprevented by sulindac therapy. Gastroenterology 1994;107:854-7.25. Nugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatouspolyposis and an ileorectal anastomosis: A cause for concern. Br J Surg 1992;79:1204-6.26. Leite JS, Isidro G, Martins M, Regateiro F, Albuquerque O, Amaro P et al. Is prophylacticcolectomy indicated in patients with MYH-associated polyposis? Colorect Dis2005;7:327-3127. The Polyposis Registry, London, UK. Protocol for the management of patients withpolyposis. A guide for medical staff. 200628. Remzi FH, Church JM, Bast J, LAvery IC, Strong SA, Hull TL et al. Mucosectomy vsstapeled ileal pouch-anal anastomosis in patients with familial adenomatous polyposisfunctional outcome and neoplasia control. Dis Colon Rectum 2001;44:1590-6.29. Setti-Carroro P, Nicholls RJ. Choice of prophylactic surgery for the large bowelcomponent of familial polyposis. Br J Surg 1996;83:885-92.30. Slors JF, Ponson AE, Taat CW, Bosma A. Risk of residual rectal mucosa afterproctocolectomy and ileal pouch-anal reconstruction with the double stapling technique.Dis Colon Rectum 1995;38:207-10.Concept landelijke richtlijn erfelijke darmkanker versie 7 d.d. 7 november 2007.99